222 related articles for article (PubMed ID: 2939204)
21. [Time resolved laser fluorescence microscopy of hematoporphyrin derivative in vivo].
Feyh J; Goetz A; Schneckenburger H; Müller W; Kastenbauer E
Laryngorhinootologie; 1991 Jan; 70(1):41-4. PubMed ID: 1827265
[TBL] [Abstract][Full Text] [Related]
22. [Photodynamic therapy of malignant brain tumors].
Kostron H; Grunert V
Wien Klin Wochenschr; 1987 May; 99(11):389-92. PubMed ID: 2956770
[TBL] [Abstract][Full Text] [Related]
23. Cellular effects of hematoporphyrin derivative photodynamic therapy on normal and neoplastic rat bladder cells.
Shulok JR; Klaunig JE; Selman SH; Schafer PJ; Goldblatt PJ
Am J Pathol; 1986 Feb; 122(2):277-83. PubMed ID: 2936252
[TBL] [Abstract][Full Text] [Related]
24. Effect of route of administration on the selectivity of hematoporphyrin derivative for tumor tissue.
Elmer EB; Wood WC; Cohen AM; Bamberg M
J Surg Oncol; 1987 Feb; 34(2):113-9. PubMed ID: 2949116
[TBL] [Abstract][Full Text] [Related]
25. Intraneoplastic injection of methotrexate for experimental brain-tumor chemotherapy.
Tator CH; Wassenaar W
J Neurosurg; 1977 Feb; 46(2):165-74. PubMed ID: 833633
[TBL] [Abstract][Full Text] [Related]
26. Tumor-localizing and photosensitizing properties of hematoporphyrin derivative in hamster buccal pouch carcinoma.
Burns RA; Klaunig JE; Shulok JR; Davis WJ; Goldblatt PJ
Oral Surg Oral Med Oral Pathol; 1986 Apr; 61(4):368-72. PubMed ID: 2939386
[TBL] [Abstract][Full Text] [Related]
27. Photoradiation therapy of 9L-gliosarcoma in rats: hematoporphyrin derivative (types I and II) followed by laser energy.
Cheng MK; McKean J; Mielke B; Tulip J; Boisvert D
J Neurooncol; 1985; 3(3):217-28. PubMed ID: 4056851
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
El-Far M; Pimstone N
Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
[TBL] [Abstract][Full Text] [Related]
29. Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo.
Bellnier DA; Prout GR; Lin CW
J Natl Cancer Inst; 1985 Mar; 74(3):617-25. PubMed ID: 3856065
[TBL] [Abstract][Full Text] [Related]
30. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
Gonschior P; Erdemci A; Gerheuser F; Gonschior GM; Mack B; Kolbe T; Goetz AE; Höfling B
Z Kardiol; 1991 Dec; 80(12):738-45. PubMed ID: 1837968
[TBL] [Abstract][Full Text] [Related]
31. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
Wong Kee Song LM; Wang KK; Zinsmeister AR
Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
[TBL] [Abstract][Full Text] [Related]
32. Components of hematoporphyrin derivatives and their tumor-localizing capacity.
Kessel D
Cancer Res; 1982 May; 42(5):1703-6. PubMed ID: 7066890
[TBL] [Abstract][Full Text] [Related]
33. [The specific photodynamic effect of monoclonal antibodies conjugated with hematoporphyrin derivative on gastric cancer in vitro and in vivo].
Lin K
Zhonghua Yi Xue Za Zhi; 1989 Jan; 69(1):24-7, 4. PubMed ID: 2527079
[TBL] [Abstract][Full Text] [Related]
34. Glucose administration augments in vivo uptake and phototoxicity of the tumor-localizing fraction of hematoporphyrin derivative.
Thomas JP; Girotti AW
Photochem Photobiol; 1989 Mar; 49(3):241-7. PubMed ID: 2525259
[TBL] [Abstract][Full Text] [Related]
35. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse.
Bugelski PJ; Porter CW; Dougherty TJ
Cancer Res; 1981 Nov; 41(11 Pt 1):4606-12. PubMed ID: 7306978
[TBL] [Abstract][Full Text] [Related]
36. Hematoporphyrin derivative photoradiation induced damage to normal and tumor tissue of the pigmented rabbit eye.
Gomer CJ; Doiron DR; White L; Jester JV; Dunn S; Szirth BC; Razum NJ; Murphree AL
Curr Eye Res; 1984 Jan; 3(1):229-37. PubMed ID: 6228386
[TBL] [Abstract][Full Text] [Related]
37. Binding of hematoporphyrin derivative to brain tumor cells--a fluorescence spectroscopic study.
Joshi K; Joshi PG; Joshi NB
Photochem Photobiol; 1992 Jan; 55(1):113-8. PubMed ID: 1534907
[TBL] [Abstract][Full Text] [Related]
38. [Hematoporphyrin derivative (HPD) plus laser photodynamic therapy for nasopharyngeal carcinoma--analysis of 57 cases].
Sun ZQ
Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):120-2. PubMed ID: 2144816
[TBL] [Abstract][Full Text] [Related]
39. Jejunal blood flow after exposure to light in rats injected with hematoporphyrin derivative.
Selman SH; Kreimer-Birnbaum M; Goldblatt PJ; Anderson TS; Keck RW; Britton SL
Cancer Res; 1985 Dec; 45(12 Pt 1):6425-7. PubMed ID: 2933144
[TBL] [Abstract][Full Text] [Related]
40. Documentation of radioactive contaminants in tritium labeled hematoporphyrin derivative.
Gomer CJ; Little FM
Prog Clin Biol Res; 1984; 170():591-600. PubMed ID: 6241699
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
